Genmab A/S Increase Decrease Through Exercise Of Warrants Equity
Genmab A/S (GNMSF) reported Increase Decrease Through Exercise Of Warrants Equity of $23.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity · last filed 2026-02-17
DKK
| Period end | Increase Decrease Through Exercise Of Warrants Equity 6 month | Increase Decrease Through Exercise Of Warrants Equity 6 month as first filed | Increase Decrease Through Exercise Of Warrants Equity 12 month |
|---|---|---|---|
| 2024-12-31 | 129.00M DKK 6-K · filed 2025-02-12 | ||
| 2024-06-30 | 75.00M DKK 6-K · filed 2024-08-08 | ||
| 2023-12-31 | 152.00M DKK 6-K · filed 2025-02-12 | ||
| 2023-06-30 | 103.00M DKK 6-K · filed 2024-08-08 | ||
| 2022-12-31 | 280.00M DKK 6-K · filed 2025-02-12 | ||
| 2022-06-30 | 34.00M DKK 6-K · filed 2023-08-03 | ||
| 2021-12-31 | 135.00M DKK 6-K · filed 2024-02-14 | ||
| 2021-06-30 | 46.00M DKK 6-K · filed 2022-08-10 | ||
| 2020-12-31 | 140.00M DKK 6-K · filed 2023-02-22 | ||
| 2020-06-30 | 71.00M DKK 6-K · filed 2021-08-11 | ||
| 2019-12-31 | 65.00M DKK 6-K · filed 2022-02-16 | ||
| 2019-06-30 | 39.00M DKK 6-K · filed 2020-08-12 | 38.67M DKK 6-K · filed 2019-08-14 | |
| 2018-12-31 | 75.00M DKK 6-K · filed 2021-02-23 | ||
| 2018-06-30 | 60.66M DKK 6-K · filed 2019-08-14 | ||
| 2017-12-31 | 215.00M DKK 20-F · filed 2020-03-30 |
USD
| Period end | Increase Decrease Through Exercise Of Warrants Equity 6 month | Increase Decrease Through Exercise Of Warrants Equity 12 month |
|---|---|---|
| 2025-12-31 | $23.00M 20-F · filed 2026-02-17 | |
| 2025-06-30 | $7.00M 6-K · filed 2025-08-07 | |
| 2024-12-31 | $19.00M 20-F · filed 2026-02-17 | |
| 2024-06-30 | $11.00M 6-K · filed 2025-08-07 | |
| 2023-12-31 | $21.00M 20-F · filed 2026-02-17 |